Finally, in conditions that were unresponsive to CpG + OX40 alone, the addition of anti-CTLA-4 restored the tumor curing ability of CpG + OX40 in A20-bearing mice, but not B78-bearing mice. This evidence concerns the gene TNFRSF4 and neoplasm.